Categories: News

Liopa reaches milestones in 2021 with lipreading technology

  • Expanded recognition of lipreading technology has increased inbound demand by more than 300%
  • First commercial sale achieved with Lancashire Teaching Hospitals NHS Trust
  • SRAVI won three recognitions this year, underscoring the importance of the technology

BELFAST, NORTHERN IRELAND – 20 December 2021Liopa reached milestones in 2021 with its lipreading technology, culminating in the first commercial sale of its SRAVI app to an NHS Trust. SRAVI is an ‘ultra-easy’ lipreading application that requires just a smartphone. It assists the voiceless by using AI algorithms to read words that they are mouthing.

Some of the milestones Liopa achieved in 2021 include:

More about Liopa’s SRAVI app
SRAVI brings a voice to the voiceless, by using AI algorithms to decipher speech from lip movements. Patients simply need to mouth words (from a predefined phrase list) into their smartphone’s camera, and SRAVI app will read out what they are trying to say. SRAVI stands for ‘speech recognition app for the voice impaired.’ Throughout the investigation into the app’s usefulness, it was proven that SRAVI reads lips with up to 95% accuracy. Further clinical evidence can be found at www.sravi.ai/evidence.html.

Notes to Editors

About Liopa’s SRAVI application:
SRAVI brings a voice to the voiceless through a mobile phone-based lipreading app. Find out more at www.sravi.ai.

About Liopa:
Liopa is one of the world’s only startups focused on automated lip reading, using deep learning techniques. Based in Belfast, Northern Ireland, Liopa has been borne out of PhD research at Queen’s University Belfast. Find out more at www.liopa.ai.

Press contact
Emily McDaid
Marketing Manager, Liopa
Emily.mcdaid@liopa.co.uk
+44 (0)745 609 4649

Ends

Source: RealWire

Staff

Recent Posts

BioSonic Bloom: What Published Research Says About 528 Hz and 432 Hz Audio Frequency Programs

An In-Depth Analysis of Digital Sound Frequency Programs, Binaural Beats Research, and Key Considerations for…

9 hours ago

Best TRT Injection for 2026: Fridays Lists Prescription Testosterone in Injectable and Oral Formats as Men Compare Telehealth Hormone Options

Independent analysis examines Fridays' published TRT program structure, delivery format options, and what clinical research…

9 hours ago

How Does Ozempic Work For Weight Loss? Best Weight Loss Supplement Launch By PhenQ

Ozempic for Weight Loss: Does It Work and Is It Safe? Read PhenQ Details –…

9 hours ago

Best NAD+ Injection for 2026: Sprout Health Lists Compounded NAD+ at $149 First Month as Telehealth Longevity Programs Expand

Prescription NAD+ Injection Access, At-Home Administration Models, Compounding Standards, and What Consumers Should Know Before…

9 hours ago

Is SynergyRx GLP-1 Legitimate? Platform Lists Compounded Semaglutide at $200 With Oral Tablet Options

Telehealth Provider Offers FDA-Approved and Compounded Weight Loss Medications in All 50 States, Subject to…

1 day ago